CONTIN, MANUELA MARIA ANTONIA
 Distribuzione geografica
Continente #
NA - Nord America 4.694
AS - Asia 3.276
EU - Europa 2.635
SA - Sud America 189
AF - Africa 186
Continente sconosciuto - Info sul continente non disponibili 167
OC - Oceania 7
Totale 11.154
Nazione #
US - Stati Uniti d'America 4.631
SG - Singapore 905
VN - Vietnam 799
CN - Cina 744
IT - Italia 651
GB - Regno Unito 515
DE - Germania 330
HK - Hong Kong 305
SE - Svezia 288
IN - India 164
BR - Brasile 133
RU - Federazione Russa 132
FR - Francia 128
UA - Ucraina 125
NL - Olanda 116
IE - Irlanda 103
JP - Giappone 62
BD - Bangladesh 59
KR - Corea 57
FI - Finlandia 50
CI - Costa d'Avorio 48
ZA - Sudafrica 47
TG - Togo 41
JO - Giordania 37
EE - Estonia 35
CA - Canada 34
AR - Argentina 32
BG - Bulgaria 32
CH - Svizzera 30
BE - Belgio 22
PH - Filippine 22
SC - Seychelles 22
TH - Thailandia 21
ES - Italia 15
PL - Polonia 14
ID - Indonesia 13
TW - Taiwan 13
AT - Austria 11
MX - Messico 10
TR - Turchia 10
MY - Malesia 9
SA - Arabia Saudita 9
HR - Croazia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
NG - Nigeria 7
PK - Pakistan 6
CL - Cile 5
CO - Colombia 5
MA - Marocco 5
PE - Perù 5
AU - Australia 4
DK - Danimarca 4
DZ - Algeria 4
GR - Grecia 4
IQ - Iraq 4
JM - Giamaica 4
RO - Romania 4
RS - Serbia 4
CY - Cipro 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
GT - Guatemala 3
KZ - Kazakistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
AZ - Azerbaigian 2
BB - Barbados 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
IR - Iran 2
IS - Islanda 2
LT - Lituania 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MG - Madagascar 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 10.984
Città #
Singapore 608
Ashburn 459
Southend 426
Chandler 333
Ann Arbor 318
Fairfield 310
Hong Kong 282
San Jose 275
Houston 180
Hanoi 174
Ho Chi Minh City 174
Santa Clara 163
Woodbridge 158
Seattle 146
Bologna 136
Wilmington 124
Hefei 116
Cambridge 115
Council Bluffs 113
Princeton 113
Beijing 106
Dublin 103
Boardman 96
Jacksonville 80
Los Angeles 76
Lauterbourg 53
Turin 51
Dallas 50
Milan 49
Abidjan 48
Redmond 48
Tokyo 48
New York 45
Seoul 44
Westminster 43
Lomé 41
Helsinki 40
Nanjing 40
Buffalo 39
Amman 37
Padova 36
Frankfurt am Main 35
Berlin 33
Sofia 31
Florence 30
Haiphong 27
Shanghai 25
Dong Ket 24
São Paulo 24
Bern 23
Chicago 21
Jinan 21
Saint Petersburg 21
Bremen 20
Brussels 20
Redondo Beach 20
Orem 18
Da Nang 17
Dearborn 17
Rome 17
San Diego 16
Shenyang 16
The Dalles 16
Bengaluru 15
Guangzhou 15
Phoenix 15
Toronto 15
Jiaxing 13
Atlanta 12
Changsha 12
Medford 12
Nuremberg 12
Tianjin 12
Warsaw 12
Brooklyn 11
Des Moines 11
Mülheim 11
Bangkok 10
Biên Hòa 10
Hangzhou 10
Johannesburg 10
Munich 10
Naples 10
Redwood City 10
Amsterdam 9
Bến Tre 9
Chennai 9
Hebei 9
Hải Dương 9
Jakarta 9
London 9
Mahé 9
Modena 9
San Francisco 9
Thái Nguyên 9
Can Tho 8
Cesena 8
Fuzhou 8
Montreal 8
Ninh Bình 8
Totale 6.775
Nome #
Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy 412
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 361
Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy 297
DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism 276
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. 271
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease. 268
Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 254
Supervised versus unsupervised technology-based levodopa monitoring in Parkinson’s disease: an intrasubject comparison 251
Mathematical modeling and parameter estimation of levodopa motor response in patients with Parkinson disease 237
Volumetric absorptive microsampling coupled with UHPLC-MS/MS for the determination of Lyso-Gb3 as Fabry disease diagnostic biomarker 231
Apparecchiatura per l'esecuzione di test psicomotori. 220
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 217
Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease 213
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 212
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy. 212
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy 198
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 195
A mathematical model of levodopa medication effect on basal ganglia in parkinson’s disease: An application to the alternate finger tapping task 194
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 192
Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations 190
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 190
Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic Monitoring 189
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 189
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 187
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 187
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 182
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness. 177
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. 174
Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? 174
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. 173
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy 169
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 167
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 166
Liver transplant reverses biochemical imbalance in mitochondrial neurogastrointestinal encephalomyopathy 164
Iodine-123-meta-iodobenzylguanidine myocardial scintigraphy in isolated autonomic failure: Potential red flag for future multiple system atrophy 162
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. 159
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. 159
CPAP treatment lowers sympathetic nerve activity and blood pressure in hypertensive obstructive sleep apnoea patients. 156
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. 155
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 152
Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson’s disease 149
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 146
A rapid and simple uhplc-ms/ms method for quantification of plasma globotriaosylsphingosine (Lyso-gb3) 144
Il trattamento con CPAP riduce l'attività simpatica e la pressione arteriosa in pazienti con Sindrome delle Apnee Ostruttive nel Sonno ed ipertensione. 142
Assessing dopaminergic function in early onset Parkinson's disease linked to homozygous PINK1 mutation. 141
Il monitoraggio terapeutico dei farmaci antiepilettici 139
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset 138
HPLC-UV analysis of thymidine and deoxyuridine in plasma of patients with thymidine phosphorylase deficiency 132
Polisomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. 131
Development and validation of volumetric absorptive microsampling coupled with UHPLC-MS/MS for the analysis of gamma-hydroxybutyric acid in human blood 127
Intrasubject reproducibility of supine norepinephrine plasma concentrations in patients with cardiovascular sympathetic failure 124
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list 122
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. 118
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome 110
Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort 109
TELEmedicine for EPIlepsy Care (TELE-EPIC): Protocol of a randomised, open controlled non-inferiority clinical trial 104
Il monitoraggio terapeutico dei farmaci in neurologia 102
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey 101
TYMP Variants Result in Late-Onset Mitochondrial Myopathy With Altered Muscle Mitochondrial DNA Homeostasis 98
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors 92
Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam 68
Cerebrospinal Fluid Concentrations of Nimodipine Correlate With Long-term Outcome in Aneurysmal Subarachnoid Hemorrhage: Pilot Study 66
Autonomic failure in a case of Chiari malformation type I 66
Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex 49
Autonomic nervous system function in myotonic dystrophy 39
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone 34
Severe dysautonomic onset of Guillain-Barré syndrome with good recovery. A clinical and autonomic follow-up study 31
Totale 11.154
Categoria #
all - tutte 30.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.227 0 35 95 92 104 70 40 100 82 123 255 231
2022/20231.335 140 198 72 152 81 98 50 75 241 25 131 72
2023/2024431 23 66 32 41 42 89 24 21 28 25 10 30
2024/20251.409 65 186 138 96 252 71 87 35 14 120 49 296
2025/20263.607 319 292 277 292 432 210 423 131 709 245 132 145
2026/2027558 189 369 0 0 0 0 0 0 0 0 0 0
Totale 11.154